BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2881319)

  • 1. Haloperidol-induced emotional defecation: a possible model for neuroleptic anxiety syndrome.
    Russell KH; Hagenmeyer-Houser SH; Sanberg PR
    Psychopharmacology (Berl); 1987; 91(1):45-9. PubMed ID: 2881319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic-induced emotional defecation: effects of pimozide and apomorphine.
    Sanberg PR
    Physiol Behav; 1989 Aug; 46(2):199-202. PubMed ID: 2602459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic-induced defecation in rats as a model for neuroleptic dysphoria.
    Sachdev P; Loneragan C; Westbrook F
    Psychiatry Res; 1993 Apr; 47(1):37-45. PubMed ID: 8100080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic-induced emotional defecation: effects of scopolamine and haloperidol.
    Sanberg PR; Russell KH; Hagenmeyer-Houser SH; Giordano M; Zubrycki EM; Garver DL
    Psychopharmacology (Berl); 1989; 99(1):60-3. PubMed ID: 2506605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors.
    Sanberg PR
    Nature; 1980 Apr; 284(5755):472-3. PubMed ID: 7189016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mecamylamine effects on haloperidol-induced catalepsy and defecation.
    Sanberg PR; Newman MB; Manresa JJ; Potts SE; Alvarez F; Cahill DW; Shytle RD
    Int J Neurosci; 2001 Jul; 109(1-2):81-90. PubMed ID: 11699343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic haloperidol-amphetamine interactions and mesolimbic dopamine.
    Lynch MR; Kuhn HG; Carey RJ
    Neuropsychobiology; 1988; 19(2):97-103. PubMed ID: 3226530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.
    Calderon SF; Sanberg PR; Norman AB
    Brain Res; 1988 May; 450(1-2):403-7. PubMed ID: 2969764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration.
    Ward RP; Dorsa DM
    Neuroscience; 1999 Mar; 89(3):927-38. PubMed ID: 10199625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation.
    Korf J; Sebens JB
    J Neurochem; 1987 Feb; 48(2):516-21. PubMed ID: 2878979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration.
    Kulkarni SK; Bishnoi M; Chopra K
    Indian J Exp Biol; 2009 Feb; 47(2):91-7. PubMed ID: 19374163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy.
    Ossowska K; Karcz M; Wardas J; Wolfarth S
    Eur J Pharmacol; 1990 Jul; 182(2):327-34. PubMed ID: 1975782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcription factor NGFI-B (Nur77) and retinoids play a critical role in acute neuroleptic-induced extrapyramidal effect and striatal neuropeptide gene expression.
    Ethier I; Beaudry G; St-Hilaire M; Milbrandt J; Rouillard C; Lévesque D
    Neuropsychopharmacology; 2004 Feb; 29(2):335-46. PubMed ID: 14603264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic domperidone fails to increase striatal spiperone binding sites despite hyperprolactinemia: comparison with chronic haloperidol.
    Morgan DG; Sinha YN; Finch CE
    Neuroendocrinology; 1984 May; 38(5):407-10. PubMed ID: 6728123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional selectivity of neuroleptic drugs: an argument for site specificity.
    Borison RL; Diamond BI
    Brain Res Bull; 1983 Aug; 11(2):215-8. PubMed ID: 6138135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in catalepsy response in inbred rats during chronic haloperidol treatment is not predictive of the intensity of behavioral hypersensitivity which subsequently develops.
    Kinon BJ; Kane JM
    Psychopharmacology (Berl); 1989; 98(4):465-71. PubMed ID: 2505286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional tolerance to haloperidol-induced catalepsy is not caused by striatal dopamine receptor supersensitivity.
    de Graaf CJ; Korf J
    Psychopharmacology (Berl); 1986; 90(1):54-7. PubMed ID: 3094062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the time course of haloperidol-induced up-regulation of rat striatal and mesolimbic dopamine receptors.
    Prosser ES; Csernansky JG; Hollister LE
    Life Sci; 1988; 43(8):715-20. PubMed ID: 2901023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of different types of cortical lesions on drug-induced catalepsy in rats: a pharmacological analysis.
    Worms P; Willigens MT; Continsouza-Blanc D; Lloyd KG
    Eur J Pharmacol; 1985 Jul; 113(1):53-9. PubMed ID: 2864264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic nicotine use blocks haloperidol-induced increase in striatal D2-dopamine receptor density.
    Prasad C; Spahn SA; Ikegami H
    Biochem Biophys Res Commun; 1989 Feb; 159(1):48-52. PubMed ID: 2522303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.